MedTrace Logo

The Turkish Version of the WUSPI

NCT04954053 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-07-08

No results posted yet for this study

Summary

Wheelchair users frequently experience shoulder pain. It has been determined that in our country, the subjective assessment methods that will help to determine and monitor shoulder pain severity of wheelchair users are limited. The purpose of this study is to adapt the original English version of the Wheelchair Users Shoulder Pain Index into Turkish and to assess its validity and reliability.

Firstly, the original English version of WUSPI was translated into Turkish and culturally adapted, then applied to 100 wheelchair users to investigate the validity of the scale. The reliability of the scale was assessed by internal consistency and test-retest analysis and found a high internal consistency. Validation of WUSPI-Tr was assessed by the concurrent validity method. To establish concurrent validity, WUSPI scores were compared to SPADI and ASES scores by Spearman correlation analysis. There was a positively excellent correlation with SPADI and, negatively excellent correlation with ASES. As a result, it is determined tath the Turkish version of WUSPI-Tr is a valid and reliable tool.

Conditions

  • Shoulder Pain

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Şeyda ÖZAL, MSc · Gazi University Faculty of Health Sciences Physiotherapy and Rehabilitation Department

  • Selda Başar, Assoc Prof · Gazi University Faculty of Health Sciences Physiotherapy and Rehabilitation Department

  • Nevin Ergun, Prof Dr · Sanko University Faculty of Health Sciences Physiotherapy and Rehabilitation Department

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-05
Primary Completion
2017-04-26
Completion
2017-07-13

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04954053 on ClinicalTrials.gov